Merck & Co., Inc. (MRK) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been active on the tape, currently trading at $55.10, down from yesterday’s close by -0.68%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Money managers are always interested in a company that can find the right recipe of fundamental data because it reflects something important going on underneath the surface. Merck & Co., Inc. (MRK) currently trades with a market capitalization of $152.25 Billion. That value represents a market adjusting for revenues that have been falling by -2.00 % on a quarterly year/year basis as of the company’s last quarterly report.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For MRK, the company currently has $7.9 Billion of cash on the books, which is offset by $5.16 Billion current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $4.34 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.94 on a per share basis this quarter. Perhaps, that suggests something about why 75.29% of the outstanding share supply is held by institutional investors.
We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Merck & Co., Inc. recorded a 52-week high of $66.80. It is now trading 11.7% off that level. The stock is trading $62.33 its 50-day moving average by 7.23%. The stock carved out a 52-week low down at $54.41.
In recent action, Merck & Co., Inc. (MRK) has made a move of -13.01% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.32, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.62% with $2.73 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of MRK.